Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this phase 3 study is to validate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xijing Hospital

Criteria

Inclusion Criteria:

• between 18 to 75 years

• the first episode

• from onset to admission within 72 hours

• NIHSS scores:5~22

Exclusion Criteria:

• had other intracranial pathologies (e.g., tumor, infection)

• had a neurologic or psychiatric disease

• had a coexisting condition that limited their life expectancy

• had significant drug or alcohol misuse

• had high-grade carotid artery stenosis for which surgery was planned

• were pregnant or nursing

• participated in a clinical trial with an investigational drug or device within the past 3 months

• were unlikely to be available for follow-up